Q&A With Colleen Harris From the University of Calgary MS Clinic: Team Approach Benefits Multiple Sclerosis Patients in Relapse

Video

One of the scariest things a patient with multiple sclerosis can experience is a relapse of their symptoms, particularly after a period of calm. How they are treated can determine their quality of life going forward.

One of the scariest things a patient with multiple sclerosis can experience is a relapse of their symptoms, particularly after a period of stability. How they are treated can determine their quality of life going forward.

Colleen Harris, MN, NP, MSCN discussed the key parts of this team approach during the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Indianapolis. Harris also discussed the importance of recognizing what is a true relapse of the condition and how it is different from a "pseudo relapse.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.